SARON BELAY: Open Payments
NPI 1306432653 · FOREST HILL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 25 payments from 12 companies in 2025. Trend: 2023 $1,184 · 2024 $695 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $115 |
| TOLMAR, INC. | 3 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $88 |
| Endo USA, Inc. | 3 | $77 |
| PFIZER INC. | 3 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Janssen Biotech, Inc. | 1 | $33 |
| Astellas Pharma US Inc | 1 | $30 |
| Boston Scientific Corporation | 1 | $28 |
| Olympus America Inc. | 1 | $19 |
Products named: Nubeqa, Xtandi, PLUVICTO, JATENZO, ORGOVYX, AVEED, RYBREVANT, Axonics.
Industry payments across MD — which companies pay providers there.
